These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients. Diaz A; Fouilloux C; Ortiz S Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564 [No Abstract] [Full Text] [Related]
26. Who bears the costs of antidepressants in Australia? Gorham PN Med J Aust; 1995 Feb; 162(3):162-3; author reply 164. PubMed ID: 7854234 [No Abstract] [Full Text] [Related]
27. The paroxetine 352 bipolar trial: A study in medical ghostwriting. Amsterdam JD; McHenry LB Int J Risk Saf Med; 2012; 24(4):221-31. PubMed ID: 23135337 [TBL] [Abstract][Full Text] [Related]
28. One foot on the bandwagon? Pies R J Clin Psychopharmacol; 1995 Oct; 15(5):303-5. PubMed ID: 8830060 [No Abstract] [Full Text] [Related]
29. Study addresses question of preferred initial therapy for depression. Am J Health Syst Pharm; 1996 Sep; 53(17):1994. PubMed ID: 8870882 [No Abstract] [Full Text] [Related]
30. Lack of desipramine toxicity with citalopram. Ashton AK J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663 [No Abstract] [Full Text] [Related]
32. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Baca E; Garcia-Garcia M; Porras-Chavarino A Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine. Waintraub L; Septien L; Azoulay P CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119 [TBL] [Abstract][Full Text] [Related]
34. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia. Fava M; Nierenberg AA; Quitkin FM; Zisook S; Pearlstein T; Stone A; Rosenbaum JF Psychopharmacol Bull; 1997; 33(1):101-3. PubMed ID: 9133758 [TBL] [Abstract][Full Text] [Related]
35. A pattern of antidepressive effect of tryptophan & imipramine in males & females. Kline NS; Shah BK Dis Nerv Syst; 1974 Oct; 35(10):481-3. PubMed ID: 17894063 [No Abstract] [Full Text] [Related]
36. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM; Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688 [TBL] [Abstract][Full Text] [Related]
37. Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients. Rosel P; Arranz B; Vallejo J; Alvarez P; Menchon JM; Palencia T; Navarro MA J Affect Disord; 1999; 52(1-3):225-33. PubMed ID: 10357037 [TBL] [Abstract][Full Text] [Related]
38. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Goodnick PJ; Kumar AM Biol Psychiatry; 2000 May; 47(9):846-7. PubMed ID: 10819459 [No Abstract] [Full Text] [Related]
39. Paroxetine and Study 329: what we already knew and when. Sasich LD BMJ; 2015 Oct; 351():h5411. PubMed ID: 26468042 [No Abstract] [Full Text] [Related]
40. Double-blind comparison of paroxetine and nortriptyline on the postural stability of late-life depressed patients. Laghrissi-Thode F; Pollock BG; Miller MC; Mulsant BH; Altieri L; Finkel MS Psychopharmacol Bull; 1995; 31(4):659-63. PubMed ID: 8851637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]